Eric Carrera - 30 Jun 2021 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Reporting relationship: Former officer
Issuer ticker: ENSC
Reported as of: 30 Jun 2021
Net transaction value: +$30,000
SEC form: 4
Accepted by SEC: 01 Jul 2021, 19:52:16 UTC
Source filing: View source filing
Reporting owner signature: /s/ Eric Carrera

Key filing fact

Eric Carrera filed Form 4 for Ensysce Biosciences, Inc. (ENSC) on 01 Jul 2021.

Key facts

This page summarizes Eric Carrera's Form 4 filing for Ensysce Biosciences, Inc. (ENSC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2021, 19:52.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$30,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENSC transaction Derivative

Warrants

Award

Transaction value: $30,000
Shares: +30,000
Change %
Price: $1.00
Shares after: 30,000
Date: 30 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $11.50
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Eric Carrera is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Reflects warrants of Ensysce Biosciences, Inc., formerly known as Leisure Acquisition Corp. (the "Issuer"), which were acquired from the Issuer at a price of $1.00 per warrant in a private placement that closed simultaneously with the closing of the Issuer's initial public offering which were later exchanged for warrants having the same terms, except that they are non-transferable other than to permitted transferees. Pursuant to the terms of the issuance, such warrants were not eligible to become exercisable unless the Issuer consummated its initial business combination which occurred on June 30, 2021. Mr. Carrera served as the Issuer's Senior Vice President of Finance and Business Development until the closing of the business combination.